Boehringer Blocked From Making False GSK Inhaler Claims

By Lauren Berg (September 3, 2020, 10:39 PM EDT) -- A Pennsylvania federal judge on Thursday issued a preliminary injunction blocking Boehringer Ingelheim Pharmaceuticals from conveying in training materials for its sales representatives false or misleading information about rival GlaxoSmithKline LLC's inhalers for patients with chronic obstructive pulmonary disease.

U.S. District Judge Cynthia M. Rufe partially granted GSK's motion for a preliminary injunction in its suit claiming Boehringer Ingelheim has made false statements about dry powder versus aerosol inhalers, finding that GSK has shown a likelihood of success on the merits of its claim that Boehringer Ingelheim made such misleading statements in internal training documents for its sales representatives.

GSK said Boehringer Ingelheim's...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!